The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Microsoft and Meta's strong earnings reports eased investor fears of an economic slowdown amid President Trump's tariffs.

The list price for Wegovy is around $1,300 per month ... Please see our republishing guidelines for use of any other photos ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...

The tech stack includes Meta’s Llama 3.2, powered by Hewlett Packard Enterprise’s Spaceborne Computer-2 and Nvidia graphics ...

Want to dominate the XDefiant Open Beta? In this video, we break down the optimal graphics, controller, and keyboard settings ...

For all the hype surrounding weight loss injections, including Ozempic and Mounjaro, the elephant in the slimming room remains: what happens when you stop taking the injections? Wellness coach ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Article continues below Ozempic is ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...

Small compounders have until April 22 to stop making and selling versions of Novo Nordisk’s Wegovy; large compounders have until May 22. It is not clear how the F.D.A. will enforce these deadlines.